Frederick Locke, MD Program Co-Leader, Immunology, Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, tells us about the data with CAR-T cell therapy outside of clinical trials.
Advertisement